- Home
- NWTG vs RDHL Comparison
NWTG vs RDHL Comparison
Compare NWTG & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NWTG | RDHL |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.0M |
| IPO Year | 2022 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NWTG | RDHL |
|---|---|---|
| Price | $1.27 | $0.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.8K | ★ 2.4M |
| Earning Date | 05-14-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,135,000.00 | N/A |
| Revenue This Year | $53.21 | $381.91 |
| Revenue Next Year | $40.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 136.14 | N/A |
| 52 Week Low | $0.70 | $0.57 |
| 52 Week High | $2.07 | $2.79 |
Technical Indicators
Market Signals| Indicator | NWTG | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 46.55 |
| Support Level | $0.95 | $0.62 |
| Resistance Level | $1.79 | $0.85 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 25.00 | 5.98 |
Price Performance
Historical ComparisonAbout NWTG Newton Golf Company Inc.
Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.